IgA nephropathy following SARS-CoV-2 vaccination in a renal transplant recipient with a history of aristolochic acid nephropathy

Ther Apher Dial. 2022 Jun;26(3):667-668. doi: 10.1111/1744-9987.13765. Epub 2021 Nov 30.

Authors

Mislav Mokos¹, Nikolina Bašić-Jukić¹

Affiliation

¹ Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.

PMID: 34816609
DOI: 10.1111/1744-9987.13765

No abstract available

Publication types

Letter

MeSH terms

Aristolochic Acids
COVID-19 Vaccines / adverse effects
COVID-19*
Female
Glomerulonephritis, IGA*
Humans
Kidney Transplantation*
Male
SARS-CoV-2
Vaccination

Substances

Aristolochic Acids
COVID-19 Vaccines
aristolochic acid I